Medicamen Biotech Shareholding Pattern

MEDICAMEQ • Ownership data to support trade logging in Tickjournal
Promoter Holding 40.46%
FII Holding 0.06%
DII Holding 0.59%
Public Holding 33.35%
Total Shareholders 11,177
As of Sept 2025
Shareholding pattern reflects how ownership is distributed among promoters, institutions, and the public.
Use this data to analyze ownership stability and log thesis-driven trades in your Tickjournal. For current market price trends, visit the Medicamen Biotech live share price chart .

Recent Shareholding Changes

Promoter Holding Change
Mar 2025 to Sept 2025
-2.7%
FII Holding Change
Mar 2025 to Sept 2025
-0.06%
DII Holding Change
Mar 2025 to Sept 2025
-0.1%
Public Holding Change
Mar 2025 to Sept 2025
No Change

Quarterly Shareholding Trends — Use in Trading Journal

Promoter
FII
DII
Public
Government

Related Pages for Medicamen Biotech

Additional stock information and data for MEDICAMEQ

MEDICAMEQ cash flow statement
MEDICAMEQ share price history
Medicamen Biotech quarterly financials
MEDICAMEQ intrinsic value
Medicamen Biotech dividend payments
MEDICAMEQ book value
Medicamen Biotech 52-week
Medicamen Biotech P/E valuation

Shareholding Pattern Data

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Sept 2025 40.46% 0.06% 0.59% 0.05% 33.35% 25.50% 100.01% 11,177
Mar 2025 43.16% 0.12% 0.69% 0.06% 33.35% 22.63% 100.01% 10,435
Jun 2025 40.46% 0.00% 0.64% 0.05% 31.50% 27.34% 99.99% 10,808
Apr 2025 40.46% 0.22% 0.65% 0.05% 31.58% 27.04% 100.00% 10,592
Sept 2024 42.99% 0.06% 1.17% 0.00% 32.43% 23.34% 99.99% 10,792
Mar 2024 43.21% 0.11% 0.99% 0.00% 31.95% 23.74% 100.00% 10,639
Jun 2024 42.99% 0.06% 1.17% 0.00% 31.57% 24.21% 100.00% 10,652
Dec 2024 42.99% 0.05% 0.87% 0.06% 32.96% 23.08% 100.01% 10,576
Sept 2023 43.21% 0.00% 0.00% 0.00% 31.80% 24.99% 100.00% 9,419
Mar 2023 43.21% 0.00% 0.20% 0.00% 31.49% 25.10% 100.00% 8,233
Jun 2023 43.21% 0.00% 0.20% 0.00% 31.43% 25.16% 100.00% 8,272
Dec 2023 43.21% 0.21% 0.68% 0.00% 31.90% 24.00% 100.00% 10,252
Sept 2022 43.21% 0.00% 0.13% 0.00% 30.94% 25.72% 100.00% 8,418
Mar 2022 43.60% 0.00% 0.00% 0.00% 34.30% 22.10% 100.00% 9,300
Jun 2022 43.60% 0.00% 0.00% 0.00% 35.02% 21.38% 100.00% 9,107
Dec 2022 43.21% 0.00% 0.20% 0.00% 31.35% 25.24% 100.00% 8,273
Sept 2021 44.83% 0.00% 0.00% 0.00% 33.17% 21.99% 99.99% 5,595
Mar 2021 44.83% 0.00% 0.00% 0.00% 33.04% 22.12% 99.99% 4,965
Jun 2021 44.83% 0.00% 0.00% 0.00% 32.97% 22.20% 100.00% 5,263
Dec 2021 43.60% 0.00% 0.00% 0.00% 34.23% 22.18% 100.01% 9,140
Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Sept 2025 40.46% 0.06% 0.59% 0.05% 33.35% 25.50% 100.01% 11,177
Mar 2025 43.16% 0.12% 0.69% 0.06% 33.35% 22.63% 100.01% 10,435
Jun 2025 40.46% 0.00% 0.64% 0.05% 31.50% 27.34% 99.99% 10,808
Apr 2025 40.46% 0.22% 0.65% 0.05% 31.58% 27.04% 100.00% 10,592
Sept 2024 42.99% 0.06% 1.17% 0.00% 32.43% 23.34% 99.99% 10,792
Mar 2024 43.21% 0.11% 0.99% 0.00% 31.95% 23.74% 100.00% 10,639
Jun 2024 42.99% 0.06% 1.17% 0.00% 31.57% 24.21% 100.00% 10,652
Dec 2024 42.99% 0.05% 0.87% 0.06% 32.96% 23.08% 100.01% 10,576
Sept 2023 43.21% 0.00% 0.00% 0.00% 31.80% 24.99% 100.00% 9,419
Mar 2023 43.21% 0.00% 0.20% 0.00% 31.49% 25.10% 100.00% 8,233
Jun 2023 43.21% 0.00% 0.20% 0.00% 31.43% 25.16% 100.00% 8,272
Dec 2023 43.21% 0.21% 0.68% 0.00% 31.90% 24.00% 100.00% 10,252

No annual shareholding data available.